Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth Purdom et al. · Cancer Cell · 2010 · 7.7K citations · Full text

Medicine, Molecular Genetics, Oncology +12

Erratum to: The 2007 WHO classification of tumours of the central nervous system

David N. Louis, Hiroko Ohgaki, Otmar D. Wiestler et al. · Zurich Open Repository and Archive (University of Zurich) · 2007 · 4.5K citations

Medicine, Neurosurgery, Oncology +14

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

Gregory Cairncross, Meihua Wang, Edward Shaw et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +14

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

Christian Hartmann, Jochen Meyer, David Capper et al. · Acta Neuropathologica · 2009 · 1.2K citations

Medicine, Molecular Genetics, Pathology +15